前列腺癌:MR引导放疗的优势与挑战
本文讨论前列腺癌外照射放疗中MR引导放疗的机会与挑战。MR可减少靶区体积和观察者间前列腺勾画差异,最终目标是实现仅MR工作流程。多中心前瞻性研究正在进行以确定可行性和每日自适应再计划。
要点
- MR引导放疗可减少靶区体积和前列腺勾画差异。
- 仅MR工作流程是前列腺放疗的最终目标。
- 需发展多学科团队以支持高效MR引导工作流程。
核心结论
- MR引导放疗可能通过提供解剖和生物学信息进一步改善前列腺癌患者结局。
研究设计与样本
- 本文为讨论MR引导放疗机会与挑战的综述性文章。
主要发现
- MRI在前列腺癌放疗计划中已显示可减少靶区体积和观察者间前列腺勾画差异。
- 当前图像引导技术可包括侵入性操作且软组织分辨率成像差,限制准确性。
- 多中心前瞻性研究正在进行以确定MR引导前列腺放疗和每日自适应再计划的可行性。
临床怎么用
- 临床需发展和适应现有放疗多学科团队以支持高效MR引导工作流程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
External beam radiotherapy for prostate cancer is an optimal treatment choice for men with localised prostate cancer and is associated with long term disease control in most patients. Image-guided prostate radiotherapy is standard of care, however, current techniques can include invasive procedures with imaging of poor soft tissue resolution, thus limiting accuracy. MRI is the imaging of choice for local prostate cancer staging and in radiotherapy planning has been shown to reduce target volume and reduce inter-observer prostate contouring variability. The ultimate aim would be to have a MR-only workflow for prostate radiotherapy. Within this article, we discuss these opportunities and challenges, relevant due to the increasing availability of MR-guided radiotherapy. Prospective multi-centre studies are underway to determine the feasibility of MR-guided prostate radiotherapy and daily adaptive replanning. In parallel, development and adaptation of the existing radiotherapy multidisciplinary workforce is essential to enable an efficient and effective MR-guided radiotherapy workflow. This technology potentially provides us with the anatomical and biological information to further improve outcomes for our patients.
引用
- Murray J, Tree AC. Prostate cancer - Advantages and disadvantages of MR-guided RT. Clin Transl Radiat Oncol. 2019. PMID: 31341979. doi:10.1016/j.ctro.2019.03.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。